Antisense Technology
2-5A Drug May Inhibit Respiratory Syncytial Virus in Infants
Published in TB and Outbreaks Week, March 17th, 1997
RSV is the principle cause of lower respiratory infections such as pneumonia and brochiolitis in infants and children, and is responsible for at least 90,000 hospitalizations and 4,500 deaths in the United States each year.
The Cleveland Clinic, Ohio, conducted the study in collaboration with the U.S. National Institutes of Health (NIH). Gemini Technologies, Inc. is the exclusive licensee of the 2-5A antisense technology. Results of the study...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Conference Coverage (IUATLD)
Comics, Games, CD-ROMS Teach About TB - Conference Coverage (IUATLD)
Drug Resistant TB On Rise Along US-Mexican Border - Conference Coverage (IUATLD)
Global Focus, Economic Commitment Critical for TB Control - Conference Coverage (IUATLD)
Gold Miners Receive TB Treatment On The Job - Conference Coverage (IUATLD)
Involuntary Transfer of Homeless Major DOT Obstacle - Conference Coverage (IUATLD)
Simplified Medication Monitor Presented - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
